Dr. Jawad Nazir, MD

Dr. Nazir practices at Avera McKennan Hospital & University Health Center in Sioux Falls, South Dakota, part of Avera Health.

Dr. Nazir's NPI, 1972579118, was assigned on February 27, 2006. Dr. Nazir holds South Dakota license 5172.

Dr. Nazir's primary practice is Avera McKennan Hospital & University Health Center, at 1325 S Cliff Ave Post Office Box 5045, Sioux Falls, SD 57117 in Minnehaha County. The practice phone is (605) 322-8000.

Dr. Nazir's primary practice is Avera McKennan Hospital & University Health Center in Sioux Falls, South Dakota, part of Avera Health. Dr. Nazir is also affiliated with Avera Sacred Heart Hospital. The medical group on file is Avera McKennan Hospital & University Health Center. Dmand AI also links Dr. Nazir to 3 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nazir practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Nazir's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Nazir is licensed in South Dakota.

CMS data shows 658 Medicare services from Dr. Nazir across 7 procedure codes in 2024, for 357 Medicare patients. Medicare paid $64,530 for them.

CMS counts 357 Medicare patients who saw Dr. Nazir in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nazir's median patient age at 65, with 47% women.

In 2024, Dr. Nazir wrote 353 Medicare Part D claims for 94 patients. 83% of them were for generic drugs. CMS names the drug for 269 of them, across 13 drugs with 11 or more claims each, at $222,202 in total drug cost. In 2023, CMS named 271 claims across 12 drugs.

Dr. Nazir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nazir as offering telehealth.

Dmand AI links 8 papers to Dr. Nazir, published from 2010 to 2020. 2020 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents, Drug Hypersensitivity and Penicillins. Dr. Nazir has published most often in S D Med. Dr. Nazir's most frequent co-authors are Robert Nicholas Santella, MD, Jeffery L. Steers, MD and Mohammed Sami Saleh Alzoubaidi, MBBS, MPH.

CMS Open Payments shows 5 general payments to Dr. Nazir from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 52% of the total. Melinta Therapeutics, Inc. paid the most, $124.